MIAMI, Sept 14 - Compugen (Nasdaq: CGEN) of Tel Aviv, Israel announced Thursday the launch of Gencarta, a platform that provides access to the company's proprietary annotated genome, transcriptome and proteome databases.

Users of Gencarta will be able to query and browse the genome and gain access to the data on a variety of levels, the company said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.